Biotechnology industry expert
Washington D.C. Metro Area
- Current
-
- Managing Editor at Journal of Commercial Biotechnology
- Guest Lecturer at Johns Hopkins University MS/MBA in Biotechnology
- Founder at DrugPatentWatch.com
- Recommended
-
5 people have recommended Yali - Connections
-
500+
connections
- Industry
- Biotechnology
- Websites
Yali Friedman’s Summary
Yali Friedman is author of Building Biotechnology, which is widely used as a course text in biotechnology programs. He currently guest lectures for the Johns Hopkins MS/MBA program in biotechnology and has been a guest lecturer at the Tepper School of Business and University of Buffalo School of Management, teaching classes on the business of biotechnology. He has published papers on diverse topics such as strategies to cope with a lack of management talent and capital when developing companies outside of established hubs, entrepreneurship in biotechnology, and new paradigms in technology-based economic development.
Yali is managing editor of the Journal of Commercial Biotechnology, serves on the science advisory board of Chakra Biotech and the editorial advisory boards of the Biotechnology Journal and Open Biotechnology Journal.
Yali has a long history in biotechnology media, having created a Forbes "Best of the Web"-rated web site on the biotechnology industry for a NY Times company. His other projects include the Student Guide to DNA Based Computers, sponsored by FUJI Television, BiotechBlog.com, and DrugPatentWatch.com, a pharmaceutical industry competitive intelligence service based on a business plan that was awarded second place in the Panasci Entrepreneurial Awards Competition.
Yali Friedman’s Specialties:
- Author, Building Biotechnology
- Editor, Best Practices in Biotechnology Education
- Editor, Best Practices in Biotechnology Business Development
- Editorial Board at Open Biotechnology Journal (Bentham Science Publishers)
- Editorial Board at Biotechnology Journal (Wiley VCH)
- Scientific Advisory Board at Chakra Biotech (Singapore)
- Board of Directors, Center for Policy on Emerging Technologies
